SCHEMBL6905307

SCHEMBL6905307

Cc1noc2ncc(N(C=O)C(=O)Nc3ccc(F)c(C(F)(F)F)c3)c(CCCN(C)C)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 1/20 0.36
UBE2M P61081 3/20 0.36
DCUN1D1 Q96GG9 3/20 0.36
KDR P35968 5/20 0.35
RIPK1 Q13546 1/20 0.35
GRM4 Q14833 1/20 0.35
CDK8 P49336 1/20 0.35
CCR2 P41597 1/20 0.34
CCR5 P51681 1/20 0.34
THRB P10828 1/20 0.34
KIT P10721 2/20 0.34
FLT3 P36888 2/20 0.34
RAF1 P04049 1/20 0.33
AR P10275 1/20 0.33
MCHR1 Q99705 1/20 0.33
ABL1 P00519 1/20 0.33
LCK P06239 1/20 0.33
CSF1R P07333 1/20 0.33
LYN P07948 1/20 0.33
SRC P12931 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5961494 0.88 BRAF (0.40) BRAFUBE2MDCUN1D1KDRRIPK1
Hydrochloric Acid SCHEMBL5961417 0.87 BRAF (0.40) BRAFUBE2MDCUN1D1KDRRIPK1
SCHEMBL5961500 0.85 GRM4 (0.38) BRAFUBE2MDCUN1D1KDRRIPK1
SCHEMBL5961556 0.75 CCR2 (0.45) BRAFUBE2MDCUN1D1KDRCCR2
SCHEMBL5961552 0.74 CCR2 (0.47) BRAFKDRCCR2CCR5THRB
SCHEMBL5961513 0.73 CCR2 (0.46) BRAFUBE2MDCUN1D1KDRCCR2
Hydrochloric Acid SCHEMBL5961470 0.73 CCR2 (0.46) BRAFUBE2MDCUN1D1KDRCCR2
SCHEMBL5961583 0.71 CCR2 (0.48) BRAFUBE2MDCUN1D1KDRGRM4
SCHEMBL5961482 0.71 CCR2 (0.51) KDRGRM4CDK8CCR2CCR5
Hydrochloric Acid SCHEMBL5961505 0.71 CCR2 (0.47) BRAFUBE2MDCUN1D1KDRGRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040077680-A1 Antagonists of MCP-1 function and methods of use thereof TELIK, INC. 2004-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077680-A1 Antagonists of MCP-1 function and methods of use thereof CCR2, CCR1, CCL2 BRAF 957/4885UBE2M 4709/4885DCUN1D1 1608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.